Page 15 - U11248 News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from U11248. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In U11248 Today - Breaking & Trending Today
The FDA granted accelerated approval to the BTK inhibitor zanubrutinib for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma. ....
A clinical trial from India raises the possibility of huge cost savings by using ultralow immunotherapy doses in the treatment of head and neck cancer. ....
Immunotherapy combinations based on nivolumab entail lower costs for grade 3/4 adverse events than those using pembrolizumab, a finding that could inform treatment decisions. ....
One of the problems with the new subgroup of HER2 low tumors is that using current assays to measure low levels "is like weighing mice on a scale built for elephants," says one expert. ....
The combination of salvage irinotecan, vincristine, and anlotinib may be another option for refractory epithelioid sarcoma. The study was published as a preprint and has not yet been peer reviewed. ....